{
  "id": 9752710,
  "title": "Aktie im Blick: Anleger misstrauen den Zukunftsplänen von Novo Nordisk",
  "url": "https://urgent.news/2026/09/25/aktie-im-blick-anleger-misstrauen-den-zukunftsplanen-von-novo-nordisk-9752710",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-25T10:13:00.000Z",
  "source": {
    "name": "Handelsblatt",
    "slug": "handelsblatt",
    "url": "https://www.handelsblatt.com/finanzen/anlagestrategie/kolumnen/aktien-anleger-misstrauen-den-zukunftsplaenen-von-novo-nordisk/100256611.html"
  },
  "original_language": "de",
  "account": null,
  "summary": "Der Hersteller von Abnehmspritzen und Weltmarktführer für Insulinprodukte blickt weit in die Zukunft. Doch das reicht Anlegern nicht. Ein großer Wettbewerber macht es besser.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Handelsblatt",
        "title": "Stock in focus: Investors distrust Novo Nordisk's future plans",
        "url": "https://urgent.news/2026/09/25/aktie-im-blick-anleger-misstrauen-den-zukunftsplanen-von-novo-nordisk",
        "published": "2026-09-25T02:00:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}